Intravesical Treatment of Superficial Urinary Bladder Tumours with Adriamycin

Personal experience resulted in the observation that intravesical Adriamycin (ADM) is effective in some patients with multiple or diffuse papillary bladder tumours. A review of the literature shows that similar results have been obtained elsewhere, especially in Japan and Sweden. The response rate was higher if single doses of at least 50 mg were employed. Intravesical instillations of ADM appear to be valuable also in the treatment of carcinoma in situ and in prophylactic treatment after transurethral resection (TUR) of papillary bladder tumours.

Staging of Bladder Cancer

It is well established that the prognosis of cancer patients depends on several factors including: the local extension of the tumour, and the presence of single or multiple tumours; the presence or absence of lymph-node metastases and/or distant metastases; the presence or absence of neoplastic cells in lymphatics or in blood vessels; the histopathological type and architecture; the degree of cellular differentiation; the tumour — host relationship, including the patient’s immunological reactivity.

The role of neoadjuvant or adjuvant chemotherapy for invasive bladder cancer

A multicentre prospective study of prostatic volume in asymptomatic men in various continents.

Objective: To compare prostatic volumes in asymptomatic Asian men with similar controls in Europe. Patients and methods: Six centres (Beijing, Hong Kong, Jinan, Lisbon, Palermo and Stirling) independently selected asymptomatic men aged 55 y or more for assessment of prostatic volume using transrectal ultrasound (total=320 men) between 1992 and 1993. Results: Prostatic volumes in asymptomatic men were greater in Beijing than Hong Kong, Stirling and Palermo (P<0.05) and were smaller in Stirling than Beijing and Jinan (P<0.05). Conclusions: These results suggest that men from Stirling are less likely to have large prostates, but there is no evidence that men from any of the six cities are more…